TABLE 3.
Characteristic | NLPHL With T-Cell Atypia |
NLPHL Without T-Cell Atypia |
p |
---|---|---|---|
N | 11 | 24 | — |
Sex | |||
Male | 9 (81.8%) | 19 (79.2%) | NS |
Female | 2 (18.2%) | 5 (20.8%) | |
Male:female ratio | 4.5 | 3.8 | |
Median age (range) | |||
All patients | 13.8 (6–66) | 36.1 (12–73) | 0.015 |
Male | 12.2 (6–32) | 35.2 (12–59) | 0.002 |
Female | 39.9 (13–66) | 37.1 (18–73) | NS |
Predominant site of nodal involvement | 0.015* | ||
Cervical | 6 (54.5%) | 2 (8.3%) | |
Submental/ | 2 (18.2%) | 3 (12.5%) | |
submandibular | |||
Inguinal | 2 (18.2%) | 7 (29.2%) | |
Axillary | 1 (9.1%) | 5 (20.8%) | |
Parotid | 0 (0%) | 4 (16.7%) | |
Retroperitoneal | 0 (0%) | 2 (8.3%) | |
Abdominal | 0 (0%) | 1 (4.2%) | |
Relapse of NLPHL | 5/7 (71.4%) | 3/22 (13.6%) | 0.008 |
NS, not statistically significant.
P value reflects frequency of cervical involvement vs. all other nodal sites of disease.